Before we begin, I would like to remind you that we will make various remarks during this conference call that constitute forward-looking statements. All remarks that are not historical facts are hereby identified as forward-looking statements and include, among others, statements regarding the adequacy of the activities undertaken to address the questions contained in the FDA's complete response letter; our ability to obtain approval of our migraine patch; the potential benefits of and commercial prospects of our patch and other product candidates; the sufficiency of our cash and cash equivalents to fund debt service and interest obligations and continue operations until the end of the third quarter; the consequences of failing to obtain additional capital; our plans and objectives for future operations; and our expectations and beliefs. Forward-looking statements are subject to numerous risks, uncertainties and assumptions that could cause actual results to differ materially and adversely from those reflected in the statements, including those factors discussed under the heading of Risk Factors in our Form 10-K for the year ended December 31, 2011, which is on file with the SEC and available through the Investor Relations section of our corporate website. As a result, you should not rely on any such forward-looking statements. While the company may elect to update forward-looking statements at some point in the future, the company specifically disclaims any obligation to do so. Also, today's call may not be reproduced in any form without our expressed written consent.I will now turn the call over to Armando Anido, Chief Executive Officer. Armando?
NuPathe Management Discusses Q2 2012 Results - Earnings Call Transcript
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.